Skip to main content

Paxlovid News (Page 2)

Nirmatrelvir, Molnupiravir Use Lowers Risks for Omicron-Infected

MONDAY, Sept. 25, 2023 – For patients infected with omicron at high risk for progression to severe disease, treatment with nirmatrelvir or molnupiravir is associated with reductions in mortality and...

President Biden Gets COVID, Flu Shots

MONDAY, Sept. 25, 2023 – President Joe Biden has been freshly vaccinated for three major respiratory viruses that could spread widely this fall and winter. Biden got both the updated COVID booster a...

Practice Points Developed for Treatment of Outpatient COVID-19

WEDNESDAY, Sept. 20, 2023 – In an updated clinical guideline issued by the American College of Physicians and published online Sept. 19 in the Annals of Internal Medicine, living, rapid practice...

FDA Approves Paxlovid (nirmatrelvir tablets and ritonavir tablets) for Adult Patients at High Risk of Progression to Severe COVID-19

NEW YORK--(BUSINESS WIRE) May 25, 2023 – Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) approved Paxlovid™ (nirmatrelvir tablets and ritonavir tablets) for t...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

COVID-19

Paxlovid patient information at Drugs.com